Search Results

Press Releases

Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent

February 21, 2025

·

11 min read

Policy

Modra Pharmaceuticals Announces U.S. Patent Issuance for ModraDoc006/r

Modra Pharmaceuticals announced that the U.S. Patent and Trademark Office has issued to Modra U.S. Patent No. 11,571,408, covering the use of its oral taxane therapeutic ModraDoc006/r. ModraDoc006/r is an oral tablet formulation of docetaxel co-administered with ritonavir, a boosting agent that enhances bioavailability.

March 16, 2023

·

2 min read

Pharm Country

Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership

Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma, Inc. on March 4, 2024, following the change in ownership of the company from SEVER Life Sciences, B.V. to Nordic Group, B.V., a subsidiary of SEVER Life Sciences B.V., which occurred on June 1, 2023.

March 4, 2024

·

3 min read

Press Releases

MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio

January 7, 2025

·

3 min read

Press Releases

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 17, 2024

·

5 min read

Press Releases

Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study

--Six sites across the U.S. are now engaged in Phase1b study

November 19, 2024

·

5 min read

Deals

Clade Therapeutics Announces the Acquisition of Gadeta B.V.

Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.

October 2, 2023

·

4 min read

Pharm Country

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces the Launch of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye.

Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. LACRIFILL Canalicular Gel is a cross-linked hyaluronic acid derivative and is FDA-cleared to temporarily block tear drainage by the occlusion of the canalicular system.

May 29, 2024

·

3 min read

Business

Genomma Lab Internacional S.A.B. de C.V. First Quarter 2024 Earnings Results Conference Call

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”) today announced that it will report its First Quarter 2024 Earnings Results on Wednesday, April 24, 2024, after the Mexican Stock Exchange (BMV) close.

April 4, 2024

·

2 min read

Business

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.

Amring Pharmaceuticals Inc., a subsidiary of Nordic Group B.V., announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Nordic Pharma recently expanded its pharmaceutical expertise in the U.S. by acquiring Visant Medical, Inc., a leader in medical technology innovation in Dry Eye Disease.

January 15, 2024

·

6 min read